Sponsor pipeline

Liaoning Chengda Biotechnology CO., LTD clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 4

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 4
NCT06825312	Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies…	Japanese Encephalitis Vaccine	Active, Not Recruiting	2026-09-02
NCT06678373	Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in…	Japanese Encephalitis	Active, Not Recruiting	2024-12-13
Not specified
NCT07120464	Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies…	Rabies Exposure	Recruiting	2025-08-13

Get alerts when Liaoning Chengda Biotechnology CO., LTD's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.